TCL Archive Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction. April 21, 2006
TCL Archive FASEB Seeks $27.3B For NIH, Increases For Research, Training, And Infrastructure. February 1, 2002